| Ppp2r1a |
Mus musculus |
|
Ppp2r1a is differentially expressed in 77 experiments [97 up/92 dn]: 51 organism parts: liver [0 up/11 dn], hippocampus [5 up/0 dn], ...; 22 cell types: embryonic stem cell [2 up/0 dn], spermatogonium [1 up/0 dn], ...; 3 cell lines, 15 compound treatments, 11 developmental stages and 10 other conditions. |
| Ppp2r1a |
|
PPP2R1A (Homo sapiens)
paa-1 (Caenorhabditis elegans)
TPD3 (Saccharomyces cerevisiae)
Pp2A-29B (Drosophila melanogaster)
NP_476481.1 (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Armadillo-like helical, Armadillo-type fold, HEAT, HEAT, type 2 |
|
|
| antigen binding, chromosome segregation, chromosome, centromeric region, protein heterodimerization activity, protein phosphatase type 2A complex |
|
|
|
Q76MZ3
Q7TMX2
Q8C2E1
|
|
|
|
ENSMUSG00000007564
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Liver
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Hippocampus
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Hypothalamus
|
Organism part |
|
|
Testis
|
Organism part |
|
|
Embryo
|
Developmental stage |
|
|
Adult
|
Developmental stage |
|
|
Colon
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Embryonic stem cell
|
Cell type |
|
|
Cerebellum
|
Organism part |
|
|
Amygdala
|
Organism part |
|
|
Spleen
|
Organism part |
|
|
C57BL/6J
|
Strain or line |
|
|
Control
|
Compound treatment |
|
|
Pituitary gland
|
Organism part |
|
|
CBA/CaJ
|
Strain or line |
|
|
Pancreas
|
Organism part |
|
|
Preoptic
|
Organism part |
|
|
TICAM1(-/-)
|
Genotype |
|
|
SCA1 wild_type
|
Genotype |
|
|
Anterior tibialis
|
Organism part |
|
|
SCA7 knock-in
|
Genotype |
|
|
Spermatogonium
|
Cell type |
|
|
Sertoli cell
|
Cell type |
|
|
SCA1 knock-in
|
Genotype |
|
|
Spermatid
|
Cell type |
|
|
Spermatocyte
|
Cell type |
|
|
SCA7 wild_type
|
Genotype |
|
|
Partial hepatectomy
|
Injury |
|
|
Bed nucleus of the stria termi...
|
Organism part |
|
|
2-cell
|
Developmental stage |
|
|
Jejunum
|
Organism part |
|
|
MYD88(-/-)
|
Genotype |
|
|
Thyroid
|
Organism part |
|
|
Cerebral cortex
|
Organism part |
|
|
Olfactory bulb
|
Organism part |
|
|
Salivary gland
|
Organism part |
|
|
Dorsal striatum
|
Organism part |
|
|
Th1
|
Cell type |
|
|
Th2
|
Cell type |
|
|
Periaqueductal gray
|
Organism part |
|
|
Substantia nigra
|
Organism part |
|
|
1-cell
|
Developmental stage |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
ATF3(-/-)
|
Genotype |
|
|
Blastocyst
|
Developmental stage |
|
|
Mammary gland
|
Organism part |
|
|
Interleukin-2
|
Compound treatment |
|
|
AKT transgenic
|
Genotype |
|
|
PKB alpha null
|
Genotype |
|
|
Frontal cortex
|
Organism part |
|
|
Pam3CSK4 + poly I:C
|
Compound treatment |
|
|
Forebrain
|
Organism part |
|
|
E12
|
Developmental stage |
|
|
E8.5
|
Developmental stage |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Bmal1-/-
|
Genotype |
|
|
CREM(-/-)
|
Genotype |
|
|
Atrial chamber
|
Organism part |
|
|
Ercc1
|
Genotype |
|
|
Small intestine
|
Organism part |
|
|
Ovary
|
Organism part |
|
|
Fertilized egg
|
Organism part |
|
|
Constant darkness
|
Light |
|
|
12 h light:12 h dark
|
Light |
|
|
Pam2CSK4
|
Compound treatment |
|
|
E13.5
|
Developmental stage |
|
|
E15.5
|
Developmental stage |
|
|
8-cell
|
Developmental stage |
|
|
Trypanosoma congolense
|
Infection |
|
|
Uninfected
|
Infection |
|
|
Blastocysts
|
Organism part |
|
|
R848
|
Compound treatment |
|
|
Pam3CSK4
|
Compound treatment |
|
|
67NR
|
Cell line |
|
|
Resting bulk splenocytes
|
Cell type |
|
|
Quadriceps muscle
|
Organism part |
|
|
Caudal to trauma
|
Observation |
|
|
Medial gastrocnemius
|
Organism part |
|
|
Microglial cell
|
Cell type |
|
|
Stomach
|
Organism part |
|
|
Litter 2
|
Generation |
|
|
Litter 1
|
Generation |
|
|
Primary osteoblast
|
Cell type |
|
|
Pachytene spermatocyte
|
Cell type |
|
|
Lung
|
Organism part |
|
|
Vagina
|
Organism part |
|
|
Spinal cord
|
Organism part |
|
|
Cycloheximide (pretreatment)
|
Compound treatment |
|
|
SCD1-/-
|
Genotype |
|
|
Oocyte
|
Organism part |
|
|
Somatic cell
|
Cell type |
|
|
Spinal cord lower
|
Organism part |
|
|
Activated natural killer cells
|
Cell type |
|
|
Thymocyte
|
Cell type |
|
|
Macrophage
|
Cell type |
|
|
4T1
|
Cell line |
|
|
Nix null mutant
|
Genotype |
|
|
Brown fat
|
Organism part |
|
|
Chlorophenylthio-cAMP + glucos...
|
Compound treatment |
|
|
Wild_type
|
Strain or line |
|
|
BALB/c SCID
|
Strain or line |
|
|
Oviduct
|
Organism part |
|
|
Vehicle - corn oil
|
Compound treatment |
|
|
Primary chondrocyte
|
Cell type |
|
|
T8 spindal segment
|
Organism part |
|
|
Site of trauma
|
Observation |
|
|
Both ventricles
|
Organism part |
|
|
Pkd1 -/-
|
Genotype |
|
|
Trigeminal
|
Organism part |
|
|
Tristetrapolin-deficient
|
Genotype |
|
|
None
|
Gene modification |
|
|
Adenoviral vector
|
Gene modification |
|
|
CD45+
|
Cell type |
|
|
CD45-
|
Cell type |
|
|
Lymph node
|
Organism part |
|
|
Quadriceps skeletal muscle
|
Organism part |
|
|
Placenta
|
Organism part |
|
|
DBA/2J
|
Strain or line |
|
|
Cytarabine sensitive
|
Phenotype |
|
|
Cytarabine resistant
|
Phenotype |
|
|
Ara-C
|
Compound treatment |
|
|
Control diet
|
Growth condition |
|
|
Very low fat, high carbohydrat...
|
Growth condition |
|
|
Extraocular muscle
|
Organism part |
|
|
Gastrocnemius muscle
|
Organism part |
|
|
B117P
|
Cell line |
|
|
Trachea
|
Organism part |
|
|
Resting natural killer cells
|
Cell type |
|
|
Cpr-low
|
Genotype |
|
|
Megakaryocyte
|
Cell type |
|
|
Megakaryocyte progenitor
|
Cell type |
|
|
Lhx8 null
|
Genotype |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
5.5 mM glucose
|
Growth condition |
|
|
22.7 mM glucose
|
Growth condition |
|
|
1,5-naphthalenediamine
|
Compound treatment |
|
|
Oocyte
|
Developmental stage |
|
|
None
|
Compound treatment |
|
|
Interferon-gamma
|
Compound treatment |
|
|
Lipopolysaccharide + Pam2CSK4
|
Compound treatment |
|
|
|
|
|
Processing time: 0.128 secs.